Newswire

Agentic AI Trust Gap Slowing Healthcare Provider Adoption, Survey Reveals

As healthcare providers begin to embed agentic AI into their workflows, a recent survey highlights a significant trust gap that is hindering widespread adoption. The findings indicate that concerns around governance, accountability, and data security are paramount among healthcare professionals, who are cautious about integrating these advanced technologies into their systems.

This trust gap reflects a broader challenge within the pharmaceutical and healthcare sectors, where regulatory compliance and quality assurance are critical. The reluctance to fully embrace agentic AI may stem from past experiences with technology failures or data breaches, which have left providers wary of potential risks. As a result, organizations must prioritize establishing robust frameworks for AI governance to foster confidence among stakeholders.

Ultimately, addressing these trust issues is essential for the successful integration of agentic AI in healthcare. Without overcoming these barriers, the potential benefits of enhanced efficiency and improved patient outcomes may remain unrealized, stalling innovation at a time when the industry is poised for transformation.

Explore deeper: the API & FDF Intelligence database is more than a directory. It combines global coverage of APIs, excipients, and finished dosage forms with real market intelligence. You’ll find: – Price ranges for APIs, excipients, and formulations. – DMF, CEP, and GMP compliance status. – Manufacturer portfolios by product and geography. – Direct contacts for every producer and FDF holder, ready for outreach. Instead of scattered spreadsheets and endless searches, the entire picture is a few clicks away. Subscription starts at an accessible rate — see how much time and budget you save by centralizing everything.
Start your 7-day trial and see what the database can do →